Publication date: November 2026 Source: Clinical Breast Cancer, Volume 26, Issue 11 Author(s): Pavnesh Kumar, Tanun Jitwatcharakomol, Jonathan E. Schoenhals, Sierra J. Daniel, Mariella Mestres-Villanueva, Yevgeniya Gokun, Thamilini Pathmarajah, Therese Y. Andraos, Rebekah Young, Jacob M. Eckstein, Julia R. White, Jose G. Bazan, Erin Healy, Sachin R. Jhawar, Sasha J. Beyer
Feasibility and Outcomes of Concomitant Boost in Prone Hypofractionated Whole-Breast Irradiation Using 3D-Conformal Radiotherapy. // Clinical Breast Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1526820926001746?dgcid=rss_sd_all
Feasibility and Outcomes of Concomitant Boost in Prone Hypofractionated Whole-Breast Irradiation Using 3D-Conformal Radiotherapy. Clinical Breast Cancer. https://www.sciencedirect.com/science/article/pii/S1526820926001746?dgcid=rss_sd_all
“Feasibility and Outcomes of Concomitant Boost in Prone Hypofractionated Whole-Breast Irradiation Using 3D-Conformal Radiotherapy.” Clinical Breast Cancer.
@article{article40679,
title = {Feasibility and Outcomes of Concomitant Boost in Prone Hypofractionated Whole-Breast Irradiation Using 3D-Conformal Radiotherapy},
journal = {Clinical Breast Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1526820926001746?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment